Local dermatological reactions (arrows) of healthy subjects in Study 2 at 2 h after subcutaneous injection of RODD.
erythema
ERYTHEMA
Subjects A, B, and C were healthy subjects. Subject A showed mild erythema around the injection site in the 150 mg RODD group. Subject B showed erythema and mild papules around the injection site in the 300 mg RODD group, and Subject C did not show any abnormalities around the injection site in 400 mg RODD group.